Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CRISIL's other current liabilities for the quarter that ended in Jun. 2026 was ₹11,343 Mil.
CRISIL's quarterly other current liabilities
declined
from Dec. 2025 (₹5,914 Mil) to Mar. 2026 (₹0 Mil) but then
increased
from Mar. 2026 (₹0 Mil) to Jun. 2026 (₹11,343 Mil).
CRISIL's annual other current liabilities
declined
from Dec. 2023 (₹4,719 Mil) to Dec. 2024 (₹4,651 Mil) but then
increased
from Dec. 2024 (₹4,651 Mil) to Dec. 2025 (₹5,914 Mil).
The historical data trend for CRISIL's Other Current Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.
What does a Other Current Liabilities of ₹11,343 Mil mean?
CRISIL (BOM:500092) has a Other Current Liabilities of ₹11,343 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on CRISIL.
Is CRISIL's Other Current Liabilities too high?
CRISIL's current Other Current Liabilities is ₹11,343 Mil. Overall, CRISIL has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CRISIL's Other Current Liabilities compare to SPGI and CME?
CRISIL's Other Current Liabilities of ₹11,343 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Capital Markets company?
A good Other Current Liabilities depends on the Capital Markets industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on CRISIL. CRISIL's current Other Current Liabilities is ₹11,343 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CRISIL stock overvalued right now?
Based on GuruFocus' analysis, CRISIL (BOM:500092) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹5,791.05, compared to a current price of ₹4,547.65 — trading 21.5% below its estimated fair value. The current Other Current Liabilities is ₹11,343 Mil. CRISIL's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For CRISIL (BOM:500092), the current Other Current Liabilities is ₹11,343 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CRISIL (BOM:500092) Overvalued in 2026?
Based on GuruFocus' analysis, CRISIL stock appears to be undervalued.
The current stock price of ₹4,547.65 is trading 21.5% below its estimated GF Value™ of ₹5,791.05.
GuruFocus considers CRISIL to be Modestly Undervalued.
Key valuation signals for BOM:500092:
Other Current Liabilities: ₹11,343 Mil
GF Value™: ₹5,791.05 vs. price of ₹4,547.65 (21.5% below fair value)
No single metric tells the full story. See the BOM:500092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CRISIL Ltd provides research and analytics solutions for clients of all sizes. It operates through segments of Ratings services, and Research, Analytics & Solutions. The Ratings services segment includes credit ratings for corporates, banks, bank loans, credit analysis services, grading services and analytical services. The Research, Analytics and solutions segment which generates key revenue, includes research and risk solutions, industry reports, customized research assignments, subscription to data services, independent equity research (IER), IPO gradings, training, credit ratings for small and medium enterprises, advisory services and a comprehensive range of risk management tools, analytics and solutions to financial institutions, banks and corporates in India.
91GF Score
Get the complete analysis for BOM:500092
Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500092 has been successfully added to your 
